Elevated expression of truncated O-glycans, such as tumor-associated Tn and sTn, is often observed in malignant tumors such as breast cancer (BC) and colorectal cancer (CRC), which bind with c-type macrophage galactose-type lectin to evade immune surveillance, resulting in poor prognosis 16. Here, EEF1A2 is linked to breast cancer.